Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan, Iran: Seroprevalence and associated factors

Hepatitis Monthly

Volumn 10, Issue 3, 2010, Pages 188-192

  Ataei, Behrooz ^a   Tayeri, Katayoon ^b   Kassaian, Nazila ^a   Farajzadegan, Ziba ^a   Babak, Anahita ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coinfection; HBV; HCV; HIV; Iran

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DEMOGRAPHY; EDUCATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIXED INFECTION; PRISONER; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; SINGLE MAN; UNEMPLOYMENT;

EID: 77954867883     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl J Med. 2007;356(14):1445-54.
2. Sulkowski MS. Viral hepatitis and HIV coinfection. J Hepatol. 2008;48(2):353-67.
3. Sharifi-Mood B, Metanat M. Co-infection HIV/AIDs and Hepatitis C. Int J Virol. 2006;2(1):63-6.
4. Chung RT. Hepatitis C and B viruses: the new opportunists in HIV infection. Top HIV Med. 2006;14(2):78-83.
5. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. HIV and hepatitis C coinfection within the CAESAR study. HIV Med. 2004;5(3):174-9.
6. Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management. Int J Drug Policy. 2007;18(5):426-32.
7. Alter MJ. Epidemiology of viral hepatitis and HIV coinfection. J Hepatol. 2006;44(1 Suppl):S6-9.
8. Alavi S, Etemadi A. HIV/HBV, HIV/HCV and HIV/HTLV-1 co infection among injecting drug user patients hospitalized at the infectious disease ward of a training hospital in Iran. Pak J Med Sci. 2007;23(4):510-3.
9. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2010;14(1):e28-33.
10. Mohammadi M, Talei G, Sheikhian A, et al. Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCVAb) coinfection among HIV positive patients. Virol J. 2009;6:202.
11. Saravanan S, Velu V, Kumarasamy N, et al. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol. 2007;13(37):5015- 20.
12. Saiz de la Hoya P, Bedia M, Murcia J, Cebria J, Sanchez-Paya J, Portilla J. [Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison.]. Enferm Infecc Microbiol Clin. 2005;23(2):53-7.
13. Ockenga J, Stoll M, Tillmann HL, Trautwein C, Manns MP, Schmidt RE. [Coinfection of hepatitis B and C in HIVinfected patients]. Wien Med Wochenschr. 1997;147(19-20):439-42.
14. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34(6):831-7.
15. Todd CS, Abed AM, Strathdee SA, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007;13(9):1327-31.
16. Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001;154(12 Suppl):S70-7.
17. Burgermeister J. Three quarters of Russia's prisoners have serious diseases. BMJ. 2003;327(7423):1066.
18. Pourahmad M, Javady A, Karimi I, Ataei B, Kassaeian N. Seroprevalence of and risk factors associated with hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners in Iran. Infect Dis Clin Pract. 2007;15(6):368- 72.
19. Bollepalli S, Mathieson K, Bay C, et al. Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients. Sex Transm Dis. 2007;34(6):367-70.
20. Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Trop Gastroenterol. 2007;28(1):19-23.
21. Nokhodian Z, Kassaian N, Ataei B, et al. Hepatitis B Markers in Isfahan, Central Iran: A Population-Based Study. Hepat Mon. 2009;9(1):12-6.